等待开盘 05-18 09:30:00 美东时间
-0.613
-2.39%
Merck (MRK) was up around 5% premarket on Thursday after it beat top- and bottom-line estimates for Q1 and issued a narrowed outlook for 2026. The Rahway, New Jersey–based company adjusted its guidanc...
04-30 18:59
https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026
04-21 23:50